These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 415228)

  • 21. LSD, psychotogenic procedures, and brain neurohumors.
    Freedman DX
    Psychopharmacol Bull; 1975 Apr; 11(2):42-3. PubMed ID: 237298
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of some hallucinogenic drugs on the amino acid precursors of brain monoamines.
    Tonge SR; Leonard BE
    Life Sci I; 1970 Dec; 9(23):1327-35. PubMed ID: 5493000
    [No Abstract]   [Full Text] [Related]  

  • 23. [Halluciogenic substances and sleep mechanisms].
    Rougeul A; Verdeaux J
    Rev Can Biol; 1972; 31():Suppl:49-58. PubMed ID: 4538208
    [No Abstract]   [Full Text] [Related]  

  • 24. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI
    Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of hallucinogens on blind monkeys.
    Siegel RK; Brewster JM; Johnson CA; Jarvik ME
    Int Pharmacopsychiatry; 1976; 11(3):150-6. PubMed ID: 11193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological and toxicological effects of beta-3,4-methylenedioxyamphetamine isomers.
    Marquardt GM; DiStefano V; Ling LL
    Toxicol Appl Pharmacol; 1978 Sep; 45(3):675-83. PubMed ID: 725923
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence for the action of d-lysergic acid diethylamide, mescaline and bufotenine on 5-hydroxytryptamine receptors in umbilical vasculature.
    Dyer DC
    J Pharmacol Exp Ther; 1974 Feb; 188(2):336-41. PubMed ID: 4359552
    [No Abstract]   [Full Text] [Related]  

  • 28. Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism.
    Tonge SR; Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):168-76. PubMed ID: 5010826
    [No Abstract]   [Full Text] [Related]  

  • 29. EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline.
    Fairchild MD; Jenden DJ; Mickey MR; Yale C
    Pharmacol Biochem Behav; 1980 Jan; 12(1):99-105. PubMed ID: 6102770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hallucinogen-induced rotational behavior in rats.
    Fleisher LN; Glick SD
    Psychopharmacology (Berl); 1979 Apr; 62(2):193-200. PubMed ID: 111284
    [No Abstract]   [Full Text] [Related]  

  • 31. [Observations on naive behavior].
    Shibuya K
    Nihon Ishikai Zasshi; 1967 Dec; 58(11):1217-26. PubMed ID: 4969321
    [No Abstract]   [Full Text] [Related]  

  • 32. Discriminable stimuli produced by hallucinogens.
    Kuhn DM; White FJ; Appel JB
    Psychopharmacol Commun; 1976; 2(4):345-8. PubMed ID: 996285
    [No Abstract]   [Full Text] [Related]  

  • 33. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component.
    Winter JC
    J Pharmacol Exp Ther; 1971 Sep; 178(3):625-30. PubMed ID: 5571911
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of mescaline and lysergic acid diethylamide on flicker discrimination in the rat.
    Schechter MD; Winter JC
    J Pharmacol Exp Ther; 1971 May; 177(2):461-7. PubMed ID: 5568801
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurological aspects of hallucinogenic drugs.
    Logan WJ
    Adv Neurol; 1975; 13():47-78. PubMed ID: 814800
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of cross-tolerance in rats among (-)delta9-trans-tetrahydrocannabinol(delta9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25).
    Teresa M; Silva A; Carlini EA; Claussen U; Korte F
    Psychopharmacologia; 1968; 13(4):332-40. PubMed ID: 5722169
    [No Abstract]   [Full Text] [Related]  

  • 37. Interaction of LSD and other hallucinogens with dopamine-sensitive adenylate cyclase in primate brain: regional differences.
    Ahn HS; Makman MH
    Brain Res; 1979 Feb; 162(1):77-88. PubMed ID: 104775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Affective-cognitive structure and psychosis. New perspectives of the study of hallucination experience with psychodysleptics].
    Andreoli A
    Ann Med Psychol (Paris); 1976 Apr; 134(4):501-22. PubMed ID: 952433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hallucinogenic drugs and circadian rhythms.
    Davies JA; Ancill RJ; Redfern PH
    Prog Brain Res; 1972; 36():79-95. PubMed ID: 4644034
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacological action spectra of hallucinogens].
    Waser PG
    Bull Schweiz Akad Med Wiss; 1971 Jun; 27(1):39-57. PubMed ID: 5141141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.